RNS Number : 7124I
  Proventec PLC
  24 November 2008
   

    
 Press Release  24 November 2008

    Proventec Plc

    ("Proventec" or "the Group")

    Interim Results

    Proventec Plc (AIM:PROV, Alternext:ALTPC), a provider of specialist steam cleaning and coatings technologies, today announces its
interim results for the six months ended 30 September 2008.

    Highlights

 *  Group turnover up 41% to �8.18 million* (2007: �5.82 million)
 *  Pre-tax loss of �649,000 due in part to weakness in sterling (2007: �391,000
    profit**)
 *  Successful dual listing on the NYSE Euronext's Alternext market in Paris
 *  Acquired controlling stakes in Frank GmbH, a German engineering company and
    CryoJet Industrial Services BV based in Rotterdam
 *  Proventec Healthcare formed to provide specialist hygienic cleaning
    solutions for infection control and effective cleaning functions in the
    healthcare sector
 *  Guido Schoenmakers appointed to the main board as Chief Operations Director

    * Turnover figure includes a full six months of Contico compared to four months in the previous interim period
    ** The corresponding results for the period to 30 September 2007 included a profit of �615,000 on the sale of one of the non-core
investments, Ultra Motor Company Limited.

    David Chestnutt, Chief Executive of Proventec Plc, commented:  "Despite the problems of the economic slowdown and hopefully the short
term volatility of the currency markets, the Board remains confident and excited for the future of the Group. Proventec's main businesses
are focused on markets where cost is not necessarily the most important consideration and the Group remains confident that it can continue
to provide innovative and effective solutions where solutions are required."

    For further information, please contact:
 Proventec Plc
 David Chestnutt, Chief Executive  Tel: + 44 (0) 151 706 0626
 dchestnutt@proventecplc.com          www.proventecplc.com   

 Seymour Pierce Limited
 Paul Davies, Corporate Finance  Tel: + 44 (0) 20 7107 8031
 pauldavies@seymourpierce.com         www.seymourpierce.com

    Media enquiries:
 Abchurch
 Henry Harrison-Topham / Stephanie Cuthbert  Tel: +44 (0) 20 7398 7718
 stephanie.cuthbert@abchurch-group.com         www.abchurch-group.com 
    
 CHAIRMAN'S STATEMENT

    The results for the six month period ended 30 September 2008 show an encouraging increase in turnover but a reduction in net profit
compared to the same period last year, which included a profit of �615,000 on the sale of one of Proventec's non-core investments.

    During the period the Group dual-listed its shares on the NYSE Euronext's Alternext market in Paris and earlier this month the unsecured
Loan Notes 2012 were also admitted to trading on this market.  Since Proventec dual listed on Alternext, it has already witnessed increased
investor interest from outside the UK. The Group believes this listing will continue to give it access to mainland European capital markets
which, in turn, gives it greater flexibility.

    There has been a significant increase in Proventec's overhead base as the Board seeks to put in place a structure to manage the
expansion and development of the Group.  In addition there has been a reduction in margin due to exchange rate losses suffered over recent
months.  The weakness of sterling has had a significant effect on the profitability of the trading companies within the Group who
predominantly purchase in US dollars and from the Euro zone.

    The Group strategy of positioning Proventec as a specialist provider of hygienic and innovative cleaning products and services to the
healthcare market and the food industry has continued.

    In September Guido Schoenmakers was appointed to the main board as Chief Operations Director.  In addition, two senior managers have
also recently been appointed to the Group who will assist in the 'roll out' of Proventec Healthcare which is a new concept.  Proventec
Healthcare will provide a focal point for the provision of specialist hygienic cleaning solutions and products aimed specifically at the
healthcare market and its particular demands both in the UK and elsewhere.

    In the industrial sector, the Group has also completed two small but significant acquisitions during the first half of the year.  In
August 2008, Proventec acquired a 60 per cent. stake in Frank GmbH, a German engineering company, specialising in the manufacture and
assembly of high quality, reliable, industrial high pressure cleaners.  The Board believes that there will be many benefits in working with
Frank not only in producing a new range of Industrial water based cleaning solutions for Proventec as well as also growing its existing
business.

    In September 2008, the Group acquired a 60 per cent. shareholding in CryoJet Industrial Services BV based in Rotterdam. CryoJet uses in
addition to steam, a proprietary dry ice technology as a cleaning agent and the company provides a specialist cleaning service to industrial
clients in Holland.  This technology will be rolled out to other geographical markets and, together with the Osprey dry steam industrial
machine range, will offer a highly cost effective and efficient cleaning and ongoing maintenance service to industrial customers.

    The Board believes that the steps it has taken and continues to take, will help to position the Group at the forefront of innovative and
technology based cleaning solutions for both the healthcare and industrial sectors.

    The Board has previously stated that it is aware that the Group's Balance Sheet would benefit from some restructuring and in the near
future the Board will make contact with shareholders to advise them of the Board's proposals and to seek shareholder approval at a General
Meeting.  

    Peter Teerlink
    Chairman
    24 November 2008
      CHIEF EXECUTIVE'S REPORT

    Turnover in the six months to 30 September 2008 has increased in line with the Group's expectations and overall sales have remained
strong. Margins within the Group have been eroded and this has been largely due to currency losses because the majority of the products
purchased for resale by the Group are purchased in US Dollars from the Far East, mainly China and in Europe, from Italy.  In addition, the
listing of Proventec's shares and loan notes on Alternext in France and the costs involved in the acquisitions of Frank and CryoJet are
other one-off costs incurred by the Group.

    Proventec's interim results to 30 September 2007 included the profit on the balance of the monies due arising from the sale of its stake
in Ultra Motor Company Limited, one of the Group's non-core investments that was sold in October 2006.

    The level of the Group's overheads has increased as it has continued to strengthen its senior management and technical staff in Osprey
in the UK and in The Netherlands. Proventec's advertising spend and marketing budget, including attendance at an increased number of trade
exhibitions, has been maintained to ensure the Group is well positioned to take advantage of the commercial opportunities it has created in
the market.

    Hygienic Solutions

    Under the leadership of Thomas Stuecken, now supported by Guido Schoenmakers, the Group has continued to expand the niche market that
Osprey has successfully developed with its dry steam equipment and specialist tooling directed at the healthcare sector.

    Contico Manufacturing Limited has sought new products to enhance its janitorial range and in conjunction with Osprey has sourced a
disposable micro-fibre range.

    These developments lead to the formation of a new entity, Proventec Healthcare, which will act as a provider of innovative and evidence
based solutions for infection control and effective cleaning functions in the healthcare sector.

    Proventec Healthcare has appointed two new and experienced senior managers, Richard Horsfall and Michael Rollins who specialise in
procurement and research.  Proventec Healthcare will seek to source a range of effective and environmentally friendly products that combined
with dry steam and micro-fibre will provide a comprehensive package for hospitals, nursing homes and other establishments in the healthcare
sector.

    Although dry steam cleaning has been initially focused on the healthcare market, the Group also recognises that there is a larger market
in the industrial sector.  Food manufacturing companies have similar demands on the level of cleanliness and the need for a bacterially
clean environment.

    To that end Proventec has strengthened its expertise in this industrial market by the Group's strategic acquisitions of controlling
stakes in Frank GmbH and CryoJet Industrial Services BV.

    The acquisition of Frank has broadened the Group's technical and engineering skills. Frank, which has a reputation in Germany for
manufacturing reliable industrial high pressure hot water washers, will work with the Osprey technical staff to develop a range of
industrial dry steam equipment aimed at use in the food manufacturing sector where the demands of power and the ability to use 24/7 requires
reliably engineered equipment.

    As an additional service, the acquisition of CryoJet provides the Group with access to an innovative and highly efficient heavy duty
industrial cleaning service.  The process utilises dry-ice pellets of carbon dioxide, blasted on to the surface to be cleaned, at a
temperature of minus 75 degrees centigrade. The company has developed its own proprietary equipment and provides this highly specialist
cleaning service through its own team of skilled operators.  CryoJet can clean where the industrial process has baked on excessive dirt that
even dry steam cannot remove.

    Once the CryoJet process has renovated the industrial plant, dry steam cleaning will ensure the plant does not fall into such a state of
disrepair again.

    Dry-ice and dry steam working together is cost effective and can delay or prevent the need for plant refurbishment.  Effective cleaning
solutions can also extend the life of major plant assets that would otherwise be replaced with the attendant costs of new plant and
downtime.

    Preventative Coatings

    Marketing and business development work is continuing on the Magma range of fire retardant coatings for the timber, thatch and
construction market.  Magma has recently completed a trial of one of its timber impregnation products which should lead to a commercial
agreement before the end of 2008.

    Innoshield BV, a coating that prevents fading and restores the colour of plastics from ultra-violet light, is in discussions with a
company for a significant contract in the Middle East where fading from ultra-violet light is a major concern.

    Outlook

    After listing Proventec's shares on the NYSE Euronext's Alternext market in Paris, the Group has recently completed the listing of the
Loan Notes on the same market.  The Board will continue during the second half of the year with the re-structuring of our balance sheet.

    Despite the problems of the economic slowdown and hopefully the short term volatility of the currency markets, the Board remains
confident and excited for the future of the Group.  Proventec's main businesses are focused on markets where cost is not necessarily the
most important consideration and the Group remains confident that it can continue to provide innovative and effective solutions where
solutions are required.

    David Chestnutt
    Chief Executive
    24 November 2008
      CONSOLIDATED BALANCE SHEET
    AS AT 30 SEPTEMBER 2008

                                                Unaudited          Unaudited                  
                                 Notes       30 September                30            Audited
                                                     2008     September 2007         31 March 
                                                    �'000              �'000              2008
                                                                                         �'000
 Assets
 Non-current assets
 Property, plant and equipment     1                1,049                582               689
 Goodwill                          2               38,303             33,186            37,144
 Other intangible assets           3                4,697              3,410             3,855
 Available for sale financial      4                2,816              2,816             2,816
 assets
 Share of associate net assets                       (33)               (66)              (19)

                                                   46,832             39,928            44,485

 Current assets
 Inventories                                        2,678              2,230             2,232
 Trade and other receivables       5               11,937              9,472            11,448
 Cash and cash equivalents         6                1,786              1,057             4,042
 Investments held for sale         7                  100                100               100

                                                   16,501             12,859            17,822

 Total assets                                      63,333             52,787            62,307

 EQUITY AND LIABILITIES
 Equity attributable to equity
 holders of the parent
 Share capital                                     12,170             12,140            12,170
 Other reserves                                    27,991             23,497            27,458
 Retained earnings                                (1,463)            (1,891)             (855)

                                                   38,698             33,746            38,773
 Minority interest                                     22                 40                32

 Total equity                                      38,720             33,786            38,805

 Non-current liabilities
 Long term borrowings              8               16,744             10,350            16,774
 Deferred tax                                         587                870               517

 Total non-current liabilities                     17,331             11,220            17,291

 Current liabilities
 Trade and other payables          9                7,058              3,535             5,937
 Current portion of long term      8                   59              3,996                59
 borrowings
 Current tax payable                                  165                250               215

 Total current liabilities                          7,282              7,781             6,211

 Total liabilities                                 24,613             19,001            23,502

 Total equity and liabilities                      63,333             52,787            62,307


    The financial statements were approved and authorised for issue by the Board on 21 November 2008 and were signed on its behalf by D
Chestnutt. 
      
    CONSOLIDATED INCOME STATEMENT
    FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2008


                                                   Unaudited             Unaudited                 Audited
                                 Notes              6 months              6 months               12 months
                                             to 30 September  to 30 September 2007                      to
                                                        2008                                 31 March 2008
                                                       �'000                 �'000                   �'000

 Revenue                                               8,182                 5,819                  14,027
 Cost of sales                                       (4,716)               (3,226)                 (7,658)

 Gross profit                                          3,466                 2,593                   6,369
 Other income                                              -                   615                   1,125
 Distribution and                                    (3,326)               (2,291)                 (5,117)
 administrative expenses
 Finance costs                                         (747)                 (460)                 (1,020)
 Share of associates operating                          (42)                  (66)                    (19)
 loss

 (Loss)/profit before taxation          (649)                                  391                   1,338
 Income tax expense                                        -                  (90)                     (7)

 (Loss)/profit for the period                          (649)                   301                   1,331
 Minority interest                                        41                  (19)                      13

 (Loss)/profit for the period
 relating to equity                                    (608)                   282                   1,318
 shareholders
 Earnings per share
 basic                            10                   (5.0)                  0.12                    10.9
 diluted                          10                   (5.0)                  0.12                    10.9


    CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDER EQUITY
    FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2008


                                                                                                                Foreign
                                      Share       Share  Shares to be issued       Share       Retained        currency       Share
                                    capital     premium                �'000     options       earnings         reserve    warrants
                                      �'000       �'000                            �'000          �'000          �'000        �'000   Total
                                                                                                                                      �'000
 For the period ended 30
 September 2008
 At 1 April                          12,170      21,107                    -          58          (855)           4,822       1,471  38,773


 Loss for the period
 attributable to equity
 shareholders
                                          -           -                    -           -          (608)               -           -   (608)
 Unrealised exchange movement
                                          -           -                    -           -              -             212           -     212
 Issue of Shares                          -           -                  321           -              -               -           -     321

 Movement in period                       -           -                  321           -          (608)             212           -    (75)


 At 30 September 2008                12,170      21,107                  321          58        (1,463)           5,034       1,471  38,698


 For the period ended 30
 September 2007
 At 1 April                          11,565      20,641                    -          58        (2,173)             159       1,471  31,721


 Profit for the period
 attributable to equity
 shareholders
                                          -           -                    -           -            282               -           -     282
 Unrealised exchange movement
                                          -           -                    -           -              -             708           -     708
 Issue of shares                        575         460                    -           -              -               -           -   1,035

 Movement in period                     575         460                    -           -            282             708           -   2,025


 At 30 September 2007                12,140      21,101                    -          58        (1,891)             867       1,471  33,746


      CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDER EQUITY
    FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2008
    (continued)

                                                                                           Foreign
                                      Share       Share       Share       Retained        currency       Share
                                    capital     premium     options       earnings         reserve    warrants
                                      �'000       �'000       �'000          �'000          �'000        �'000   Total
                                                                                                                 �'000
 For the year ended 31 March
 2008
 At 1 April                          11,565      20,641          58        (2,173)             159       1,471  31,721

 Profit for the year
 attributable to equity
 shareholders
                                          -           -           -          1,318               -           -   1,318
 Unrealised exchange movement
                                          -           -           -              -           4,663           -   4,663
 Issue of shares                        605         466           -              -               -           -   1,071

 Movement in year                       605         466           -          1,318           4,663           -   7,052

 At 31 March 2008                    12,170      21,107          58          (855)           4,822       1,471  38,773



    CONSOLIDATED STATEMENT OF RECOGNISED INCOME AND EXPENSE
    FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2008
                                              Unaudited             Unaudited                 Audited
                                               6 months              6 months               12 months
                                                     to                    to                      to
                                           30 September    30 September 2007            31 March 2008
                                                   2008                 �'000                   �'000
                                                  �'000
                                 
 (Loss)/profit for the period                     (649)                   282                   1,331
                                 
 Net exchange differences on     
 translating foreign operations                     212                   708                   4,663
                                 
 Total recognised income and     
 expense for the period                           (437)                   990                   5,994
                                 
 Attributable to the minority                      (41)                     -                      13
 interest                        
 Attributable to equity holders  
 of the parent                                    (396)                   990                   5,981
                                 



      CONSOLIDATED CASH FLOW STATEMENT
    FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2008


                                          Unaudited 6 months     Unaudited 6 months               Audited
                                 Notes       to 30 September  to 30 September 2007          12 months to 
                                                        2008                  �'000         31 March 2008
                                                       �'000                                        �'000

 Cash flows from operating
 activities
 Cash generated from operations   11                   (768)                (1,221)               (1,411)
 Interest received                                        80                    130                   352
 Interest paid                                         (711)                  (443)               (1,140)
 Tax (paid) / received                                     -                      -                 (116)

 Net cash flow from operating                        (1,399)                (1,534)               (2,315)
 activities


 Cash flows from investing
 activities
 Acquisition of subsidiaries
 (net of cash acquired)                                (754)                (5,149)               (5,474)
 Proceeds from sale of tangible                            -                      -                     3
 assets
 Purchase of property, plant                            (73)                  (115)                 (285)
 and equipment
 Purchase of intangible assets                             -                      -                  (97)
 Share capital acquired by                                 -                     20                    20
 minority interest

 Net cash flow from investing                          (827)                (5,244)               (5,833)
 activities


 Cash flows from financing
 activities
 Proceeds from new loans                                   -                  1,362                 1,826
 Proceeds from issue of share                              -                  1,035                 5,096
 capital
 Payment of finance lease                               (30)                    (4)                  (18)
 liabilities
 Costs in issuing share capital                            -                      -                 (156)

 Net cash flow from financing                           (30)                  2,393                 6,748
 activities


 Net decrease in cash and cash                       (2,256)                (4,385)               (1,400)
 equivalents
 Cash and cash equivalents at
 beginning of the period                               4,042                  5,442                 5,442

 Cash and cash equivalents at      6
 end of the period                                     1,786                  1,057                 4,042



    ACCOUNTING POLICIES

    The principal accounting policies adopted in the preparation of these financial statements are set out below. These policies have been
consistently applied to all the years presented, unless otherwise stated. 

    Basis of preparation
    As is permitted by the AIM Rules, the directors have not adopted the requirements of IAS 34 "Interim Financial Reporting" in preparing
the interim financial statements. Accordingly the interim financial statements are not in full compliance with IFRS.  

    The financial information for the six months ended 30 September 2008 and 30 September 2007 is unaudited and does not constitute
statutory accounts within the meaning of Section 240 of the Companies Act 1985.

    The comparative figures for the year ended 31 March 2008 were derived from the statutory accounts for that year which have been
delivered to the Registrar of Companies. Those accounts received an unqualified audit report which did not contain statements under sections
237(2) or (3) of the Companies Act 1985.

    Group accounting
    Subsidiaries are those entities in which the Group has an interest of more than one half of the voting rights or otherwise has power to
govern the financial and operating policies. The existence and effect of potential voting rights that are presently exercisable or presently
convertible are considered when assessing whether the Group controls another entity.

    Subsidiaries are consolidated from the date on which control is transferred to the Group and are no longer consolidated from the date
that control ceases.  

    Where necessary, the accounting policies of subsidiaries have been changed in order to ensure consistency with the policies adopted by
the Group.

    Inter company transactions, balances and unrealised gains on transactions between Group companies are eliminated. 

    Business combinations
    The purchase method of accounting is used to account for the acquisition of subsidiaries. The cost of an acquisition is measured as the
fair value of the assets given, equity instruments issued and liabilities incurred or assumed at the date of exchange plus costs directly
attributable to the acquisition. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination
are measured initially at their fair values at the acquisition date. The excess of the cost of the acquisition over the fair value of the
Group's share of the identifiable net assets acquired is recorded as goodwill. If the cost of acquisition is less than the fair value of the
net assets of the subsidiary acquired the difference is recognised directly in the income statement. 

    Foreign currency translation
    Functional currency
    Items included in the financial statements of each entity in the Group are measured using the currency of the primary economic
environment in which the entity operates ("the functional currency"). The consolidated financial statements are presented in sterling, which
is the functional and presentation currency of the parent.

    Transactions and balances
    Foreign currency translations are translated into the functional currency using the exchange rates prevailing at the dates of the
transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation of monetary
assets and liabilities denominated in foreign currencies are recognised in the income statement.
      Group companies
    Income statements and cash flow of foreign entities are translated into the Group's functional currency at average exchange rates for
the year and their balance sheets are translated at the exchange rates ruling at the period end. 

    Goodwill and fair value adjustments arising on the acquisition of a foreign entity are treated as assets and liabilities of the foreign
entity and translated at the closing rate.

    Property, plant and equipment
    All property, plant and equipment are stated at historical cost less depreciation. Cost includes the original purchase price of the
asset and the costs attributable to bringing the assets to its working condition for its intended use. Finance costs are not included.

    Depreciation is calculated on the straight-line method to write off the cost of each asset to their residual values over their estimated
useful lives as follows.

 Fixtures, fittings and equipment  25% per annum
 Plant and machinery               25% per annum
 Computer equipment                25% per annum

    Where the carrying amount of an asset is greater than its estimated recoverable amount, it is written down immediately to its
recoverable amount. 

    Gains and losses on disposals are determined by comparing proceeds with carrying amount and are included in operating profit.

    Repairs and maintenance are charged to the income statement during the financial period in which they are incurred.  

    Goodwill
    Goodwill represents the excess of the cost of an acquisition over the fair value of the group's share of the net assets of the acquired
subsidiary at the date of acquisition. 

    Prior to 1 April 2004, the date of transition to IFRS, goodwill was amortised over its estimated useful life; such amortisation ceasing
on 31 March 2004. Goodwill is subject to impairment review, both annually and when there are indicators that the carrying value may not be
recoverable. A write down is made if the carrying amount exceeds the recoverable amount. 

    Intangible assets
    Intangible assets are stated at cost less accumulated amortisation and impairment losses. Intangible assets with indefinite useful lives
are not amortised but are tested for impairment annually.

    Impairment of non-financial assets
    Property, plant and equipment and other non-current assets, including goodwill and other intangible assets are reviewed on an annual
basis to determine whether events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. If any
such indication exists, the recoverable amount of the asset is estimated as either the higher of the asset's net selling price or value in
use; the resultant impairment (the amount by which the carrying amount of the asset exceeds its recoverable amount) is recognised as a
charge in the consolidated income statement.

    The value in use is calculated as the present value of estimated future cash flows expected to result from the use of assets and their
eventual disposal proceeds. In order to calculate the present value of estimated future cash flows the Group uses a discount rate based on
the Group's estimated weighted average cost of capital, together with any risk premium determined appropriate. Estimated future cash flows
used in the impairment calculation represents management's best view of the likely future market conditions and current decisions on the use
of each asset or asset group.

    For the purpose of assessing impairment, assets are grouped at the lowest levels at which there are separately identifiable cash flows.

    Finance leases where the Group is the lessee
    Leases of property, plant and equipment where the Group is subject to substantially all the risks and rewards of ownership, are
classified as finance leases. Finance leases are capitalised at the inception of the lease at the lower of the fair value of the leased
property or the present value of the minimum lease payments. Each lease payment is allocated between the liability and finance charges so as
to achieve a constant rate on the finance balance outstanding. The corresponding rental obligations, net of finance charges, are included in
other payables. The interest element of the finance cost is charged to the income statement over the lease period so as to produce a
constant periodic rate of interest on the remaining balance of the liability for each period. The property, plant and equipment acquired
under finance leases are depreciated over the shorter of the useful life of the asset or the lease term.  

    Where reference is made in the report and financial statements to finance leases, this includes hire purchase agreements.

    Operating leases where the Group is the lessee
    Leases where a significant portion of the risks and rewards of ownership are retained by the lessor are classified as operating leases.
Payments made under operating leases (net of any incentives received from the lessor) are charged to the income statement on a straight-line
basis over the period of the lease. Incentives received are recorded as deferred income and spread over the term of the lease on a straight
line basis. 

    Operating leases where the Group is the lessor
    Lease income is recognised over the term of the lease using the net investment method, which reflects a constant period rate of return.

    Inventories
    Inventories are stated at the lower of cost, or net realisable value. Cost of inventory represents material and a proportion of
procurement overheads. Net realisable value represents the estimated selling price less all estimated costs of completion and cost to be
incurred in marketing, selling and distribution. 

    Provisions are made for slow moving and obsolete amounts due according to the original terms of receivables. The amount of the provision
is the difference between the carrying amount and the directors' best estimate of the amount recoverable.

    Cash and cash equivalents 
    Cash and cash equivalents are carried in the balance sheet at cost. For the purpose of the cash flow statement, cash and cash
equivalents comprise cash on hand and deposits held at call with banks. 

    Employee benefits
    Defined contribution schemes
    A defined contribution plan is a pension plan under which the Group pays fixed contributions into a separate entity (a fund) and will
have no legal or constructive obligations to pay further contributions if the fund does not hold sufficient assets to pay all employees
benefits relating to employee service in the current and prior periods. Contributions are charged to the profit and loss account in the year
in which they arise. 

    Share-based payments
    The fair values of employees share option and share performance plans are calculated using the Black-Scholes model. In accordance with
IFRS 2, 'Share-based Payments' the resulting cost is charged to the income statement over the vesting period of the options. The value of
the charge is adjusted to reflect expected and actual levels of options vesting for changes in non market vesting criteria.
      Deferred tax
    Deferred tax is provided in full, using the liability method, on temporary differences arising between the tax bases of assets and
liabilities and their carrying amounts in the consolidated financial statements. However, the deferred tax is not accounted for if it arises
from initial recognition of an asset or liability in a transaction other than a business combination that at the time of the transaction
affects neither accounting nor taxable profit or loss. Deferred tax is determined using tax rates (and laws) that have been enacted or
substantially enacted by the balance sheet date and are expected to apply when the related deferred tax asset is realised or the deferred
income tax liability is settled.

    Deferred tax assets are recognised to the extent that it is probable that future taxable profit will be available against which the
temporary differences can be utilised.

    Deferred tax is provided on temporary differences arising on investments in subsidiaries and associates, except where the timing of the
reversal of the temporary difference is controlled by the Group and it is probable that the temporary difference will not reverse in the
foreseeable future. 

    Revenue Recognition
    Revenue comprises the invoiced value for the sale of goods and services net of value-added tax, rebates and discounts, and after
eliminating sales within the Group. Revenue from the sale of goods is recognised when significant risks and rewards of ownership of the
goods are transferred to the buyer, which is usually on dispatch. 

    Sales of services are recognised in the accounting period in which the services are rendered by reference to completion of the specific
transaction assessed on the basis of the actual service provided as a proportion of the total services to be performed. 

    Interest 
    Interest income is recognised on a time proportion basis, taking account of the principal outstanding and the effective rate over the
period of maturity, when it is determined that such income will accrue to the Group.  

    Financial assets
    The Group classifies its financial assets in the following categories: investments held for sale, trade and other receivables, and
available for sale investments. The classification depends on the purpose for which the financial assets were acquired. Management
determines the classification of the Group's financial assets at initial recognition and re-evaluates this designation at every reporting
date.  

    (a) Investments held for sale
    A financial asset is classified in this category if designated by management as expected to be realised within 12 months of the balance
sheet date.

    Investments are classified as held for sale in accordance with IFRS 5 if their carrying amount will be recovered principally through a
sale transaction rather than through continuing use. Such assets are measured at the lower of their carrying amount and fair value less
costs to sell.

    Gains or losses arising from changes in the fair value of these investments, including interest and dividend income, are presented in
the income statement within "other (losses)/gains - net" in the period in which they arise.

    (b) Trade and other receivables
    Trade receivables are recognised initially at fair value and subsequently measured at amortised cost using the effective interest
method, less provision for impairment. A provision for impairment of trade receivables is established when there is objective evidence that
the Group will not be able to collect all amounts due according to the original terms of receivables. Significant financial difficulties of
the debtor, probability that the debtor will enter bankruptcy or financial reorganisation, and default or delinquency in payments are
considered indicators that the trade receivable is impaired. The amount of the provision is the difference between the asset's carrying
amount and the present value of the estimated future cash flows, discounted at the effective interest rate.

    (c) Available for sale financial assets
    Available for sale financial assets are non-derivatives that are either designated in this category or not classified in any of the
other categories. They are included in non current assets unless management intends to dispose of the investment within 12 months of the
balance sheet date. 

    When investments classified as available for sale are sold or impaired, the accumulated fair value adjustments recognised in equity are
included in the income statement as "gains and losses from investment". Interest on available for sale investments calculated using the
effective interest method is recognised in the income statement. Dividends on available for sale investments are recognised in the income
statement when the Group's right to receive payments is established.

    Regular purchases and sales of investments are recognised on the date on which the Group commits to purchase or sell the asset.
Investments are initially recognised at fair value plus transaction costs for all financial assets not carried at fair value through profit
or loss. Financial assets carried at fair value through profit and loss are initially recognised at fair value and transaction costs are
expensed in the income statement. Investments are derecognised when the rights to receive cash flows from the investments have expired or
have been transferred and the Group has transferred substantially all risks and rewards of ownership. Available for sale investments and
investments held for sale are subsequently carried at fair value. 

    If the market for a financial asset is not active (and for unlisted securities), the Group establishes fair value by using valuation
techniques. These include the use of recent arm's length transactions, reference to other instruments that are substantially the same,
discounted cash flow analysis, and the option pricing models, making maximum use of market inputs and relying as little as possible on
entity specific inputs. If the fair value of an unquoted equity instrument cannot be measured reliably, it is measured at cost. 

    Impairment
    The Group assesses at each balance sheet date whether there is objective evidence that a financial asset or group of financial assets is
impaired. In the case of equity securities classified as available for sale, a significant or prolonged decline in the fair value of the
security below its cost is considered an indicator that the securities are impaired. If any such evidence exists for available for sale
financial assets, the cumulative loss is measured as the difference between the acquisition cost and the current fair value, less any
impairment loss on that financial asset previously recognised. 

    Share capital
    Ordinary Shares are classified as equity.

    Incremental costs directly attributable to the issue of new shares or options are shown in equity as a deduction, net of tax, from the
proceeds. 

    Borrowings
    Borrowings are recognised initially at fair value, net of transaction costs incurred. Borrowings are subsequently stated at amortised
cost; any difference between the proceeds (net of transaction costs) and the redemption value is recognised in the income statement over the
period of the borrowings using the effective interest method. 

    Borrowings are classified as current liabilities unless the Group has an unconditional right to defer settlement of the liability for at
least 12 months after the balance sheet date. 

    Trade payables are recognised at fair value.
      Financial risk management
    Financial risk factors
    The Group's activities expose it to currency, interest rate and credit risk.

    The Group incurs currency risk as a result of transactions that are denominated in a currency other than British Pounds. The Group does
not enter into any forward exchange contracts in order to hedge its exposure to such risk.

    The Group is exposed to credit risk in its accounts receivable and bank balances. The Group has a credit risk policy in place and the
exposure to credit risk is monitored on an ongoing basis. The Group is exposed to credit risk in relation to licence income and sale
proceeds from investments included in other debtors The directors constantly monitor this risk and have procedures to only enter into
transactions of this nature with reputable companies. Bank balances are all maintained at reputable financial institutions. 

    Accounts receivable and accounts payable, arising from normal trade transactions, are expected to be settled within normal credit
terms.

    Fair value estimation
    Financial instruments recognised on the balance sheet include bank balances and cash, investments, accounts receivable, accounts payable
and borrowings. The carrying values of financial instruments are considered to approximate their fair value.  

    Credit accounting estimates and judgments
    Estimates and judgments are continually evaluated and are based on historical experience and other factors, including expectations of
future events that are believed to be reasonable under the circumstances. 

    Critical accounting estimates and assumptions
    The Group makes estimates and assumptions concerning the future. The resulting accounting estimates will, by definition, seldom equal
the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying
amounts of assets and liabilities within the next financial year are discussed below:

    (a)    Estimated impairment of goodwill and intangible assets
        The Group tests annually whether goodwill and intangible assets have suffered any impairment, in accordance with the accounting
policy stated. The recoverable amounts of cash generating units have been determined based on value in use calculations. These calculations
require the use of estimates, as disclosed in note 3 and 4 to the financial statements. 

       (b)    Premium on redemption of loan notes
        The Group has assumed the loan notes will be converted in full and so no provision has been made for the premium due on redemption.


      (c)    Licence income receivable
        The Group has estimated the amount recoverable on licence income due based on the net present value of the cashflows using an
appropriate discount rate.
      NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
    FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2008

    1.  PROPERTY, PLANT AND EQUIPMENT

                                          Unaudited          Unaudited        Audited 
                                      30 September   30 September 2007        31 March
                                               2008              �'000           2008 
                                              �'000                              �'000
 Cost
 At 1 April                                     823                189             189
 Additions                                       73                115             285
 Acquisitions via business                      530                933             357
 combination
 Disposals                                        -                  -             (8)

 At 30 September                              1,426              1,237             823


 Depreciation
 At 1 April                                     134                 32              32
 Charge for the year                             68                 47             107
 Acquisitions via business                      175                576               -
 combination
 Disposals                                        -                  -             (5)

 At 30 September                                377                655             134

 Net book value
 At 30 September                              1,049                582             689


    2.  GOODWILL

                                          Unaudited          Unaudited        Audited 
                                      30 September   30 September 2007        31 March
                                               2008              �'000           2008 
                                              �'000                              �'000
 Cost
 At 1 April                                  37,144             29,873          29,873
 Additions                                      999              2,729           3,430
 Exchange rate movement                         160                584           3,841


 Net carrying amount at 30                   38,303             33,186          37,144
 September


    Goodwill is carried at cost less any impairment. Impairment testing has been carried out by comparing goodwill plus associated operating
assets with the value in use, calculated as the net present value of discounted future cash flows.

    Key assumptions used in goodwill impairment reviews are based on previous experience and are:

    *     Cash flow forecasts for a 3 year period have been used for the cash generating unit which comprises the acquired businesses.
    *     Growth in net revenue assumptions amount to 30% to 2009, 30% to 2010, 30% to 2011, 10% thereafter.
    *     The cash flows have been discounted using the estimated WACC of 7.5%.
      3.    OTHER INTANGIBLE ASSETS
        
                                  Unaudited          Unaudited        Audited 
                              30 September   30 September 2007        31 March
                                       2008              �'000           2008 
                                      �'000                              �'000
 Cost
 At 1 April                           3,864              3,306           3,306
 Additions                              851                 34             164
 Disposals                                -                  -            (68)
 Exchange rate movement                  16                 84             462

 At 30 September                      4,731              3,424           3,864


                                          Unaudited          Unaudited        Audited 
                                      30 September   30 September 2007        31 March
                                               2008              �'000           2008 
                                              �'000                              �'000
 Amortisation
 At 1 April                                       9                 14              14
 Charge for period                               25                  -              47
 Disposals                                        -                  -            (52)

 At 30 September                                 34                 14               9


 Net carrying amount at 30                    4,697              3,410           3,855
 September


    The reasons and factors that played a role in determining that development and patents have an indefinite life are that they are in the
early stages and so the Group cannot determine reliably how long they will generate cash flows for.

        Key assumptions used in intangible asset impairment reviews are based on:-

    *     Cash flow forecasts for a 3 year period have been used for the cash generating unit which comprises the acquired businesses.
    *     Growth in net revenue assumptions amount to 30% to 2009, 30% to 2010, 30% to 2011, 10% thereafter.
    *     The cash flows have been discounted using the estimated WACC of 7.5%.


    4.    AVAILABLE FOR SALE FINANCIAL ASSETS

                                          Unaudited          Unaudited        Audited 
                                      30 September   30 September 2007        31 March
                                               2008              �'000           2008 
                                              �'000                              �'000
 At cost
 At 1 April                                   2,816              2,816           2,816
 Additions                                        -                  -               -

 Net carrying value at 30                     2,816              2,816           2,816
 September 


      Details of the investments held are as follows:-

                                No. of     Type of       % Share   Cost    Nature of business
                                Shares      Shares  Capital Held  �'000

 Biocote Limited               696,693    Ordinary         31.5%    704        Powder Coating

 Firestop Chemicals Limited  6,946,256    Ordinary         44.1%  1,072        Fire retardant
                                     -  Loan Notes             -  1,035         chemicals and
                                                                                    processes

    The investments in Biocote Limited and Firestop Chemicals Limited are classified as held for sale because the group does not have
significant influence over these entities as other board members are significant shareholders, who if they vote together, have control of
the company.  

    The loan notes held in Firestop Chemicals Limited are repayable on 30 September 2012. The interest is receivable at a rate 2% above base
with a minimum rate of 6%.

    These investments are held at cost because their fair value cannot be determined reliably because there is no active market and are not
profitable at this stage of development.  

    5.    TRADE AND OTHER RECEIVABLES
         
                                          Unaudited          Unaudited        Audited 
                                      30 September   30 September 2007        31 March
                                               2008              �'000           2008 
                                              �'000                              �'000

 Trade debtors                                6,251              4,511           5,914
 Other debtors                                  656                626           1,457
 Prepayments and accrued income               5,030              4,335           4,077

                                             11,937              9,472          11,448


    6.    CASH AND CASH EQUIVALENTS
         
                                    Unaudited          Unaudited        Audited 
                                30 September   30 September 2007        31 March
                                         2008              �'000           2008 
                                        �'000                              �'000

 Cash at bank and in hand               1,786              1,057           4,042


      7.    INVESTMENTS HELD FOR SALE

                                 Unaudited 30 September           Unaudited        Audited 
                                                    2008  30 September 2007        31 March
                                                   �'000              �'000           2008 
                                                                                      �'000

 At 1 April                                          275                275             275
 Disposals                                             -                  -               -

 At 30 September                                     275                275             275


 Impairment and amortisation
 At 1 April                                          175                175             175

 At 30 September                                     175                175             175


 Net carrying amount at 30                           100                100             100
 September 



                          No. of   Type of       % Share   Cost    Nature of business
                          Shares    Shares  Capital Held  �'000

 Oxis Energy Limited  12,061,124  Ordinary            4%    100  Early stage
                                                                 developer of lithium
                                                                 sulphide batteries

        The directors have resolved to dispose of their investments in Oxis Energy Limited within the next 12 months.

    8.    FINANCIAL LIABILITIES - BORROWINGS

                                          Unaudited          Unaudited        Audited 
                                      30 September   30 September 2007        31 March
                                               2008              �'000           2008 
                                              �'000                              �'000
 Current
 Loan due within one year                         -              3,987               -
 Finance lease commitments due
 within one year                                 59                  9              59

                                                 59              3,996              59

 Non-current
 Loans due between two and five               2,625                  -           2,625
 years
 Loan notes between two and                  14,058                  -          14,058
 five years
 Loan notes over five years                       -             10,345               -
                                             16,683             10,345          16,683

 Finance lease commitments
 Between one and two years                       61                  5              91
                                             16,744             10,350          16,774

                                             16,803             14,346          16,833

    The loan due within one year attracts interest at 0.5% above the lender's borrowings rate. The loan and accumulated interest can be
converted into ordinary shares after 31 December 2006. The loan has a repayment date of 31 March 2010. 

        The loan notes comprise 10,500,000 8.5% fixed rate convertible guaranteed unsecured loan notes. The interest on the loan notes
recognised in the profit and loss account for the period is �647,000. The effective interest rate on the loan notes is 8.86%. The loan notes
are repayable in one final payment on 31 December 2012 which attracts a premium of 22.5% of the principal amount outstanding. The loan notes
are convertible into ordinary shares at the option of the holder at 280p per share.

    9.    TRADE AND OTHER PAYABLES
        
                                          Unaudited          Unaudited        Audited 
                                      30 September   30 September 2007        31 March
                                               2008              �'000           2008 
                                              �'000                              �'000
 Invoice discounting                          1,635                  -           1,676
 Trade creditors                              2,425              1,679           2,139
 Other taxes and social                         351                348             318
 security
 Other creditors                                660                 17             649
 Accruals                                     1,987              1,491           1,155

                                              7,058              3,535           5,937


    10.    EARNINGS PER SHARE

    Basic
    Basic earnings per share is calculated by dividing the profit attributable to equity shareholders by the weighted average number of
ordinary shares in issue during the year.

                                         Unaudited 30          Unaudited
                                           September   30 September 2007        Audited 
                                                 2008              �'000        31 March
                                                �'000                              2008 
                                                                                   �'000
 (Loss)/profit attributable to                  (608)                282           1,318
 equity holders of the company


 Weighted average number of
 ordinary shares in issue                      12,170            234,235          12,009
 (thousands)

 Basic earnings per share                       (5.0)               0.12            10.9
 (pence)


    Diluted
    Diluted earnings per share is calculated by adjusting the weighted average number of Ordinary Shares outstanding to assume conversion of
all dilutive potential Ordinary Shares. The Group has two dilutive potential Ordinary Shares namely its share options and convertible loan
notes. For the share options, a calculation is done to determine the number of shares that could have been acquired at fair value
(determined as the average annual market share price of the Group's shares) based on the monetary value of the subscription rights attached
to outstanding share options. The number of shares calculated as above is compared with the number of shares that would have been issued
assuming the exercise of the share options. The conversion of the outstanding warrants and convertible loan notes do not result in a
decreased earnings per share or increased loss per share and are therefore not treated as dilutive potential Ordinary Shares.
      Diluted

                                         Unaudited 30          Unaudited
                                           September   30 September 2007        Audited 
                                                 2008              �'000        31 March
                                                �'000                              2008 
                                                                                   �'000

 (Loss)/profit attributable to                  (608)                282           1,318
 equity holders of the company


 Weighted average number of
 ordinary shares in issue                      12,170            234,305          12,009
 (thousands)
 Adjustments for share options                      -                  -               -
 (thousands)

 Weighted average number of
 ordinary shares for diluted                   12,170            234,305          12,009
 earnings per share (thousands)

 Diluted earnings per share                     (5.0)               0.12            10.9
 (pence)



    11.    CASH FLOW FROM OPERATING ACTIVITIES

                                         Unaudited 30          Unaudited
                                           September   30 September 2007        Audited 
                                                 2008              �'000        31 March
                                                �'000                              2008 
                                                                                   �'000

 (Loss)/profit before taxation                  (649)                391           1,338
 Depreciation of tangible and                      93                 47             154
 intangible assets 
 Finance costs                                    747                460           1,020
 Share of loss in joint venture                    42                 66              19
 Profit on disposal of                              -              (615)         (1,125)
 investment

 Changes in working capital
 (excluding effect of                             233                349           1,406
 acquisitions and disposals)
 (Increase)/decrease in                          (97)              (174)           (176)
 inventory
 (Increase)/decrease in trade                   (680)            (1,554)         (3,402)
 and other receivables
 (Decrease)/increase in trade                   (224)                158             761
 and other payables 

 Cash outflow from operations                   (768)            (1,221)         (1,411)




    - Ends-

This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
IR PUGCPGUPRGQG

Proventec (LSE:PROV)
Historical Stock Chart
From Jul 2024 to Aug 2024 Click Here for more Proventec Charts.
Proventec (LSE:PROV)
Historical Stock Chart
From Aug 2023 to Aug 2024 Click Here for more Proventec Charts.